We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FA icon
2676
First Advantage
FA
$4.05B
$74K ﹤0.01%
+3,735
New +$75.8K
FORM icon
2677
FormFactor
FORM
$8.79B
$74K ﹤0.01%
2,042
-11,253
-85% -$444K
IAG icon
2678
IAMGOLD
IAG
$10.5B
$74K ﹤0.01%
25,137
-23,553
-48% -$79.3K
INN
2679
Summit Hotel Properties
INN
$670M
$74K ﹤0.01%
7,889
-3,666
-32% -$36.3K
LAZR
2680
DELISTED
Luminar Technologies
LAZR
$74K ﹤0.01%
+225
New +$74.2K
MODV
2681
DELISTED
ModivCare
MODV
$74K ﹤0.01%
439
-249
-36% -$37.3K
SPT icon
2682
Sprout Social
SPT
$604M
$74K ﹤0.01%
830
-1,264
-60% -$87.6K
AERI
2683
DELISTED
Aerie Pharmaceuticals
AERI
$74K ﹤0.01%
4,615
-1,280
-22% -$22K
AFSM icon
2684
First Trust Active Factor Small Cap ETF
AFSM
$122M
$73K ﹤0.01%
2,746
-7,634
-74% -$198K
AMWL icon
2685
American Well
AMWL
$231M
$73K ﹤0.01%
291
+223
+328% +$64.3K
CAPR icon
2686
Capricor Therapeutics
CAPR
$223M
$73K ﹤0.01%
14,302
+7,109
+99% +$30.1K
CPS icon
2687
Cooper-Standard Automotive
CPS
$504M
$73K ﹤0.01%
2,534
+1,669
+193% +$51.6K
FLGT icon
2688
Fulgent Genetics
FLGT
$524M
$73K ﹤0.01%
797
-1,371
-63% -$109K
LX
2689
LexinFintech Holdings
LX
$242M
$73K ﹤0.01%
+5,964
New +$60.4K
MTRX icon
2690
Matrix Service
MTRX
$326M
$73K ﹤0.01%
6,890
+2,588
+60% +$31.2K
NOBL icon
2691
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$73K ﹤0.01%
+1,602
New +$72.6K
RYTM icon
2692
Rhythm Pharmaceuticals
RYTM
$7.95B
$73K ﹤0.01%
3,735
+1,461
+64% +$30.3K
SPYV icon
2693
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.6B
$73K ﹤0.01%
1,853
+1,153
+165% +$45.6K
VCYT icon
2694
Veracyte
VCYT
$3.72B
$73K ﹤0.01%
1,826
-39,047
-96% -$1.67M
AMTI
2695
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$73K ﹤0.01%
1,581
+642
+68% +$30.4K
AEMD icon
2696
Aethlon Medical
AEMD
$1.62M
$72K ﹤0.01%
+4
New +$46.1K
AHCO icon
2697
AdaptHealth
AHCO
$696M
$72K ﹤0.01%
2,629
-3,964
-60% -$113K
BEP icon
2698
Brookfield Renewable
BEP
$9.8B
$72K ﹤0.01%
+1,859
New +$73.6K
CLNE icon
2699
Clean Energy Fuels
CLNE
$355M
$72K ﹤0.01%
7,120
-16,739
-70% -$173K
CTRN icon
2700
Citi Trends
CTRN
$618M
$72K ﹤0.01%
831
-1,047
-56% -$96.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.